Non-Coding RNAs in Glioma Microenvironment and Angiogenesis
- PMID: 34803608
- PMCID: PMC8595242
- DOI: 10.3389/fnmol.2021.763610
Non-Coding RNAs in Glioma Microenvironment and Angiogenesis
Abstract
Glioma, especially glioblastoma, is the most common and lethal brain tumor. In line with the complicated vascularization processes and the strong intratumoral heterogeneity, tumor-associated blood vessels in glioma are regulated by multiple types of cells through a variety of molecular mechanisms. Components of the tumor microenvironment, including tumor cells and tumor-associated stromata, produce various types of molecular mediators to regulate glioma angiogenesis. As critical regulatory molecules, non-coding RNAs (ncRNAs) inside cells or secreted to the tumor microenvironment play essential roles in glioma angiogenesis. In this review, we briefly summarize recent studies about the production, delivery, and functions of ncRNAs in the tumor microenvironment, as well as the molecular mechanisms underlying the regulation of angiogenesis by ncRNAs. We also discuss the ncRNA-based therapeutic strategies in the anti-angiogenic therapy for glioma treatment.
Keywords: anti-angiogenic therapy; glioblastoma; non-coding RNAs; tumor microenvironment; tumor vascularization.
Copyright © 2021 Li, Zhang, Xia, Niu and Zhou.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Exosomal non-coding RNAs in glioma progression: insights into tumor microenvironment dynamics and therapeutic implications.Front Cell Dev Biol. 2023 Nov 1;11:1275755. doi: 10.3389/fcell.2023.1275755. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38020906 Free PMC article. Review.
-
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.Mol Ther Oncolytics. 2021 Dec 22;24:262-287. doi: 10.1016/j.omto.2021.12.015. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2021. PMID: 35071748 Free PMC article. Review.
-
Non-coding RNAs in Regulating Tumor Angiogenesis.Front Cell Dev Biol. 2021 Sep 20;9:751578. doi: 10.3389/fcell.2021.751578. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34616746 Free PMC article. Review.
-
Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment.Noncoding RNA. 2023 Aug 28;9(5):52. doi: 10.3390/ncrna9050052. Noncoding RNA. 2023. PMID: 37736898 Free PMC article. Review.
-
The Role of Non-Coding RNAs in Glioma.Biomedicines. 2022 Aug 20;10(8):2031. doi: 10.3390/biomedicines10082031. Biomedicines. 2022. PMID: 36009578 Free PMC article. Review.
Cited by
-
Isolinderalactone inhibits glioblastoma cell supernatant-induced angiogenesis.Oncol Lett. 2022 Aug 2;24(4):328. doi: 10.3892/ol.2022.13448. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36039052 Free PMC article.
-
Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma.Cancers (Basel). 2023 Jul 26;15(15):3800. doi: 10.3390/cancers15153800. Cancers (Basel). 2023. PMID: 37568616 Free PMC article.
-
Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance.Front Physiol. 2023 Jun 14;14:1199225. doi: 10.3389/fphys.2023.1199225. eCollection 2023. Front Physiol. 2023. PMID: 37389120 Free PMC article. Review.
-
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).Int J Oncol. 2022 Jun;60(6):76. doi: 10.3892/ijo.2022.5366. Epub 2022 May 4. Int J Oncol. 2022. PMID: 35506469 Free PMC article. Review.
-
Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme.Transl Cancer Res. 2023 Jan 30;12(1):13-30. doi: 10.21037/tcr-22-1592. Epub 2022 Dec 22. Transl Cancer Res. 2023. PMID: 36760384 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials